Search Results 151-160 of 24195 for B cell lymphomas
... B-cell non-Hodgkin lymphoma (NHL), and in previously untreated participants with diffuse large B-cell lymphoma (DLBCL). Everolimus and Lenalidomide in ...
They begin in lymphocytes called B cells. This cancer affects parts of the nervous system that control thinking, movement and vision, so symptoms often include ...
Histologically proven large B-cell lymphoma, including the following types defined by (Swerdlow et al, 2016): · Relapsed or chemotherapy-refractory disease, ...
... b-cell malignancies. Lurbinectedin + Doxorubicin ... cell lymphoma (DLBCL) and Grade 3 follicular lymphoma (FL3). ... It binds to a protein called CD20, which is ...
The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.
Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma · Overview · Participation eligibility · Participating Mayo Clinic ...
Clinical Trials · GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 · More about research at Mayo ...
... B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG). Researchers say that adding the ...
A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma · Share · Facebook · Twitter.
He is board certified in hematology and has a special interest in lymphoma, stem cell transplantation, and gene therapy. Dr. Johnston has been involved in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!